Plustick Management’s Ginkgo Bioworks DNA Stock Holding History

Plustick Management’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-27,500	Closed	-$1.46M	–	25
2023 Q1	$1.46M	Sell	27,500 -15,000	-35%	-$951K	1.25%	18
2022 Q4	$2.87M	Sell	42,500 -16,437	-28%	-$1.51M	2.26%	15
2022 Q3	$7.36M	Buy	58,937 +6,437	+12%	+$767K	5.59%	6
2022 Q2	$5M	Buy	52,500 +13,750	+35%	+$1.68M	4.1%	9
2022 Q1	$6.25M	Buy	+38,750	New	+$7.54M	3.94%	10

Other funds holding DNA

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACG

Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Plustick Management's DNA Position: Q2 2023 in Review

Plustick Management sold out of Ginkgo Bioworks (DNA) in Q2 2023, closing a stake of 27,500 shares — an estimated $1.46M sold.

Plustick Management first reported a position in DNA in Q1 2022 and held it in 5 quarters. The position peaked at $7.36M in Q3 2022. 315 funds tracked by Wall St. Rank hold DNA as of Q2 2023.

Plustick Management reported no remaining Ginkgo Bioworks position as of Q2 2023 after selling out during the quarter.
Plustick Management sold 27,500 Ginkgo Bioworks shares in Q2 2023, an estimated $1.46M.
Plustick Management first reported a position in Ginkgo Bioworks in Q1 2022 and held it in 5 quarters.
Plustick Management's Ginkgo Bioworks position peaked at $7.36M in Q3 2022.
315 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2023.

Based on Plustick Management's 13F filing for Q2 2023, filed 14 Aug 2023.